Page last updated: 2024-12-07
2'-hydroxy-2,4,4,7,4'-pentamethylflavan
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2'-hydroxy-2,4,4,7,4'-pentamethylflavan: has fish toxin, antibacterial, and melanogenesis inhibitory activities [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 97820 |
| SCHEMBL ID | 4665594 |
| MeSH ID | M0536629 |
Synonyms (25)
| Synonym |
|---|
| in-531 |
| 2'-flavanol,4,4,4',7-pentamethyl- |
| 2,4,4',7-pentamethyl-2'-flavanol |
| nsc-44176 |
| phenol,4-dihydro-2,4,4,7-tetramethyl-2h-1-benzopyran-2-yl)-5-methyl- |
| 2'-hydroxy-2,4,7,4'-pentamethylflavan |
| in 531 |
| 2,4,4,4',7-pentamethyl-2'-flavanol |
| brn 0279169 |
| nsc 44176 |
| 2'-flavanol, 2,4,4,4',7-pentamethyl- |
| phenol, 5-methyl-2-(2,4,4,7-tetramethyl-3,4-dihydro-2h-1-benzopyran-2-yl)- |
| 5-methyl-2-(2,4,4,7-tetramethylchroman-2-yl)phenol |
| inulavosin |
| 6022-36-2 |
| nsc44176 |
| 5-methyl-2-(2,4,4,7-tetramethyl-3h-chromen-2-yl)phenol |
| 2'-hydroxy-2,4,4,7,4'-pentamethylflavan |
| AKOS004908096 |
| 5-methyl-2-(2,4,4,7-tetramethyl-3,4-dihydro-2h-1-benzopyran-2-yl)phenol |
| 5-17-04-00566 (beilstein handbook reference) |
| SCHEMBL4665594 |
| phenol, 2-(3,4-dihydro-2,4,4,7-tetramethyl-2h-1-benzopyran-2-yl)-5-methyl- |
| 5-methyl-2-(2,4,4,7-tetramethyl-3,4-dihydro-2h-chromen-2-yl)phenol |
| DTXSID101033952 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.28
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.28) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||